Human Cancer Biobank

The Cancer Human Biobank (caHUB) may be a National Cancer Organized biobanking foundation that was created to back specialized biospecimen and information acquirements for cancer investigate. The caHUB foundation backed both the Genotype-Tissue Expression (GTEx) and Biospecimen Preanalytical Factors (BPV) programs. Extra assets created from the caHUB program incorporate SOPs for tall quality biospecimen collection, preparing, capacity and dissemination, and a few open source computer program and lexicon items.

The caHUB infrastructure consists of the following components:

  • Biospecimen Source Sites (BSS)

  • Comprehensive Biospecimen Resource (CBR

  • Comprehensive Data Resource (CDR)

  • Pathology Resource Center (PRC)

  • Molecular Analysis Facilities (MAFs)

    Related Conference of Human Cancer Biobank

    February 25-25, 2021

    4th International Conference on Clinical Case Reports

    New York, USA
    March 03-03, 2021

    7th Global Summit on Heart Care and Diseases

    London, UK
    March 16-17, 2021

    4th International Conference on Ear Nose and Throat

    Sydney, Australia
    March 22-23, 2021

    7th World Congress on Anesthesia and Critical Care

    Paris, France
    March 23-24, 2021

    2nd Annual Congress on Medicine

    Tokai, Japan
    April 19-20, 2021

    8th Asian Herbal and Traditional Medicine summit

    Tokyo, Japan
    April 23-23, 2021

    Webinar on Neurology and Neural Disease

    Paris, France
    April 23-24, 2021

    Webinar on Cancer Treatment and Prevention

    Paris, France
    April 26-27, 2021

    Euro Ophthalmology and Eye Surgery Conference

    Dubai, UAE
    July 26-27, 2021

    2nd World Medicine Congress

    London, UK
    August 02-03, 2021

    International Medical Devices Expo

    Zurich, Switzerland
    October 14-15, 2021

    14th World Congress on Personalized Medicine and Novel Therapy

    Singapore, Singapore

    Human Cancer Biobank Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in